Veröffentlichungen

Straesser, Julia, Kim C. Honselmann, Rudiger Braun, Thaer S. A. Abdalla, Markus Kist, Monika Klinkhammer-Schalke, Sylke Zeissig, u. a. 2024. „Recurrence Trends in Ampullary and Distal Bile Duct Carcinoma – a Nation-Wide Analysis of the German Cancer Registries“. GASTROENTEROLOGY 166 (5): S1887–S1887.

Zeissig, Sylke, Monika Klinkhammer-Schalke, Benjamin Barnes, Johannes Bruns, Bianca Franke, Tobias Hartz, Anne Hennings, u. a. 2024. „Plato2: Nationwide Platform for Linking and Analysing Oncology Research Data“. ONCOLOGY RESEARCH AND TREATMENT 47 (Februar):163–163.

Voelkel, Vinzenz, Brunhilde Steinger, Michael Koller, Monika Klinkhammer-Schalke, und Patricia Lindberg-Scharf. 2024. „Defeated and yet Not Quite over – Long-Term Memories of Cancer“. ONCOLOGY RESEARCH AND TREATMENT 47 (Februar):55–56.

Bohne, Annika, Elena Grundler, Helge Knuettel, Vinzenz Voelkel, und Alois Fuerst. 2024. „Influence of Laparoscopic versus Open Surgery on Humoral Immunity in Patients with Colorectal Cancer: A Systematic Review and Meta-Analysis“. ONCOLOGY RESEARCH AND TREATMENT 47 (Februar):53–54.

Sokotukhin, Vitaly, Michael Gerken, Monika Klinkhammer-Schalke, und Armin Pauer. 2024. „Impact of the COVID-19 Pandemic on Incidence and Therapy of High-Grade Gliomas“. ONCOLOGY RESEARCH AND TREATMENT 47 (Februar):44–44.

Schoffer, Olaf, Kees Kleihues-Van Tol, Fabian Baum, Bianca Franke, Vinzenz Voelkel, Stefan Rolf Benz, Judith Hansinger, u. a. 2024. „Cancer Research Data Center – Conception, Challenges and Analysis Potential of the Linkage of Care-Related Data“. ONCOLOGY RESEARCH AND TREATMENT 47 (Februar):21–21.

Hatzipanagiotou, Maria Eleni, Miriam Pigerl, Michael Gerken, Sophie Raepple, Verena Zeltner, Madeleine Hetterich, Peter Ugocsai, u. a. 2024. „Timing of Neoadjuvant or Adjuvant Therapy in Patients with Early Triple Negative Breast Cancer“. ONCOLOGY RESEARCH AND TREATMENT 47 (Februar):9–9.

Fiedler, Mathias, Alisa Off, Andreas Gärtner, Gero Brockhoff, Jonas Eichberger, Maximilian Gottsauner, Johannes G. Schuderer, u. a. 2024. „Increased PD-1/PD-L1 Immune Checkpoint Expression Is Associated With Oral Squamous Cell Carcinoma in Never-Smokers and Never-Drinkers“. Head & Neck, Oktober.

Fischl, Anna, Michael Gerken, Patricia Lindberg-Scharf, Tareq M. Haedenkamp, Katharina Rosengarth, Andrea Hillberg, Martin Vogelhuber, u. a. 2024. „Health-Related Quality of Life and Treatment Satisfaction of Patients with Malignant IDH Wild-Type Gliomas and Their Caregivers“. Current Oncology (Toronto, Ont.) 31 (10): 6155–70.

Götz, Linda, Tananeh Ansafi, Michael Gerken, Monika Klinkhammer-Schalke, Anna Fischl, Markus J. Riemenschneider, Martin Proescholdt, u. a. 2024. „Effect of Antibiotic Drug Use on Outcome and Therapy-Related Toxicity in Patients with Glioblastoma-A Retrospective Cohort Study“. Neuro-Oncology Advances 6 (1): vdae170.

Grundler, Elena, Michael Gerken, Sabine Schatz, Luca Dittrich, Matthias Biebl, Andreas D. Rink, Werner Kneist, Felix Aigner, Vinzenz Völkel, und Alois Fürst. 2024. „Transanal Total Mesorectal Excision: Short- and Long-Term Results of Four Certified Colorectal Cancer Centers in Germany“. International Journal of Colorectal Disease 39 (1): 132.

Hansinger J, Völkel V, Gerken M, et al (2024) Endometrial Cancer – Long-Term Survival in Certified Cancer Centers and Non-Certified Hospitals: Comparative Analysis Based on a Large German Retrospective Cohort Study (WiZen). Geburtshilfe Frauenheilkd 84:979–988.

Friebel S, Thater A, Völkel V, Klinkhammer-Schalke M, Müller-Nordhorn J, Emmert M. Qualitätsgesicherte Behandlung in zertifizierten Versorgungsnetzwerken von Patientinnen mit Mammakarzinom in der Region Oberfranken: Eine Analyse auf Basis von Bayerischen Krebsregisterdaten. Gesundheitswesen. Juli 2024;86(7):515–22.

Schoffer O, Wimberger P, Gerken M, Bierbaum V, Bobeth C, Rößler M, u. a. Die Behandlung in zertifizierten Brustkrebszentren verbessert die Überlebenschancen von Patient*innen mit Brustkrebs. Senologie – Zeitschrift für Mammadiagnostik und -therapie. Juni 2024;21(2):121–31.

Kupf I, Thanner G, Gerken M, Crispin A, Braess J. How accurate is clinical prognostication by oncologists during routine practice in a general hospital and can it be improved by a specific prognosis training programme: a prospective interventional study. BMJ Open. 18. Juni 2024;14(6):e081661.

Abdalla TSA, Duhn J, Klinkhammer-Schalke M, Zeissig SR, Kleihues-van Tol K, Honselmann KC, u. a. Oncological Outcomes and Patterns of Recurrence after the Surgical Resection of an Invasive Intraductal Papillary Mucinous Neoplasm versus Primary Pancreatic Ductal Adenocarcinoma: An Analysis from the German Cancer Registry Group of the Society of German Tumor Centers. Cancers. Juni 2024;16(11):2016.

Lugnier C, Sommerlatte S, Attenberger U, Beer AJ, Bentz M, Benz SR, u. a. Prioritization and Resource Allocation in the Context of the COVID-19 Pandemic: Recommendations for Colorectal and Pancreatic Cancer in Germany. Oncol Res Treat [Internet]. Juni 2024;47(6).

Fernandez M, Gerken M, Ortmann O, Ignatov A, Klinkhammer-Schalke M, Sturm-Inwald E. Einfluss des Cavity Shaving auf Nachresektionsraten bei Patienten mit primär invasivem Mammakarzinom und DCIS bei brusterhaltender Chirurgie -eine bevölkerungsbasierte Kohortenstudie. In: Geburtshilfe und Frauenheilkunde [Internet]. Georg Thieme Verlag KG; 14.06.2024. S. P28.

Hatzipanagiotou ME, Zeltner V, Gerken M, Pigerl MC, Räpple S, Roth J, u. a. Einfluss des neoadjuvanten Chemotherapieregimes auf das Outcome bei Patientinnen mit triple negativem Mammakarzinom: Real World Data. In: Geburtshilfe und Frauenheilkunde [Internet]. Georg Thieme Verlag KG; 14.06.2024. S. FV01.

Klinkhammer-Schalke M, Kleihues van Tol K, Jurkschat R, Meyer M, Katalinic A, Holleczek B, u. a. Der einheitliche onkologische Basisdatensatz (oBDS). Forum. 1. Juni 2024;39(3):191–5.

Papathemelis T, Ortmann O, Kohl C, Neuser P, Tol KK van, Klinkhammer-Schalke M, u. a. Treatment of endometrial cancer from 2000 to 2020 in Germany: a retrospective population based cohort study. J Cancer Res Clin Oncol. 27. Mai 2024;150(5):279.

Baecher H, Gerken M, Knoedler L, Knoedler S, Alfertshofer M, Klinkhammer-Schalke M, u. a. Complete lymph node dissection in cutaneous melanoma patients with positive sentinel lymph node: Outcome and predictors in a retrospective cohort study over 16 years. J Plast Reconstr Aesthet Surg. Mai 2024;92:33–47.

Hatzipanagiotou ME, Pigerl M, Gerken M, Räpple S, Zeltner V, Hetterich M, u. a. Abstract PS04-01: Clinical impact of timing of systemic therapy in patients with early triple negative breast cancer. Cancer Research. 2. Mai 2024;84(9_Supplement):PS04-01.

Kowalski C, Rueckher J, Hartz T, Wesselmann S, Klinkhammer-Schalke M, Ortmann O. Collaboration between cancer registries and certified centers. Onkologie. April 2024;30(4):257–64.

Kemper M, Schoffer O, Gerken M, Bierbaum V, Bobeth C, Rößler M, u. a. Profitieren Kopf-Hals-Tumorpatient:innen von der Behandlung in zertifizierten Zentren? Spezifische Ergebnisse der WiZen-Studie für Kopf-Hals-Tumoren. In: Laryngo-Rhino-Otologie [Internet]. Georg Thieme Verlag KG; 19.04.2024.

Kemper M, Schoffer O, Gerken M, Bierbaum V, Bobeth C, Rößler M, u. a. Do head and neck cancer patients benefit from treatment in certified centres? Specific results of the WiZen study for head and neck cancers. In: Laryngo-Rhino-Otologie [Internet]. Georg Thieme Verlag KG; 19.04.2024.

Friebel S, Thater A, Voelkel V, Klinkhammer-Schalke M, Mueller-Nordhorn J, Emmert M. Quality-assured treatment in certified breast cancer centre networks in Upper Franconia, Germany: An analysis based on data of the Bavarian Cancer Registry. Gesundheitswesen [Internet]. 2. April 2024;

Petruch N, Servin Rojas M, Lillemoe KD, Castillo CF del, Braun R, Honselmann KC, u. a. The impact of surgical-oncologic textbook outcome in patients with stage I to III pancreatic ductal adenocarcinoma: A cross-validation study of two national registries. Surgery. 1. April 2024;175(4):1120–7.

Kuenzel J, Duerr S, Vester S, Zeman F, Huppertz G, Koller M, u. a. The effects of Phoniatric PREhabilitation in Head and Neck Cancer patients on Aspiration and Preservation of Swallowing (PREHAPS): study protocol of a monocentric prospective randomized interventional outcome-blinded trial. Trials. 22. März 2024;25(1):211.

Schmitt J, Schoffer O, Klinkhammer-Schalke M. In Reply. Dtsch Arztebl Int. 22. März 2024;121(6):203–4.

Bohne A, Grundler E, Knüttel H, Völkel V, Fürst A. Impact of laparoscopic versus open surgery on humoral immunity in patients with colorectal cancer: a systematic review and meta-analysis. Surg Endosc. Februar 2024;38(2):540–53.

Schoffer O, Wimberger P, Gerken M, Bierbaum V, Bobeth C, Rößler M, u. a. Treatment in Certified Breast Cancer Centers Improves Chances of Survival of Patients with Breast Cancer: Evidence Based on Health Care Data from the WiZen Study. Geburtshilfe Frauenheilkd. Februar 2024;84(2):153–63.

Abdalla TSA, Bolm L, Klinkhammer-Schalke M, Zeissig SR, Kleihues van Tol K, Bronsert P, u. a. When Should Lymphadenectomy Be Performed in Non-Metastatic Pancreatic Neuroendocrine Tumors? A Population-Based Analysis of the German Clinical Cancer Registry Group. Cancers (Basel). 19. Januar 2024;16(2):440.

Hatzipanagiotou ME, Pigerl M, Gerken M, Räpple S, Zeltner V, Hetterich M, u. a. Clinical impact of delaying initiation of adjuvant chemotherapy in patients with early triple negative breast cancer. Breast Cancer Res Treat. 19. Januar 2024;

Bierbaum V, Bobeth C, Roessler M, Gerken M, Kleihues-van Tol K, Reissfelder C, u. a. Treatment in certified cancer centers is related to better survival in patients with colon and rectal cancer: evidence from a large German cohort study. World J Surg Oncol. 6. Januar 2024;22(1):11.

Inwald EC, Klinkhammer-Schalke M, Müller-Nordhorn J, Voigtländer S, Gerken M, Behrens B, u. a. Auswirkungen der COVID-19-Pandemie auf das Krebsgeschehen in Deutschland. Gynäkologie. 1. Januar 2024;57(1):3–8.